- Home
- KRNT vs EVMN Comparison
KRNT vs EVMN Comparison
Compare KRNT & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRNT | EVMN |
|---|---|---|
| Founded | 2002 | 2020 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.3M | 628.9M |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | KRNT | EVMN |
|---|---|---|
| Price | $13.90 | $17.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $19.75 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 467.7K | 96.8K |
| Earning Date | 11-05-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $210,041,000.00 | $13,000,000.00 |
| Revenue This Year | $3.86 | N/A |
| Revenue Next Year | $2.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.17 | ★ 160.00 |
| 52 Week Low | $11.93 | $16.70 |
| 52 Week High | $34.29 | $24.03 |
Technical Indicators
Market Signals| Indicator | KRNT | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 54.74 | N/A |
| Support Level | $13.70 | N/A |
| Resistance Level | $14.63 | N/A |
| Average True Range (ATR) | 0.46 | 0.00 |
| MACD | 0.13 | 0.00 |
| Stochastic Oscillator | 63.65 | 0.00 |
Price Performance
Historical ComparisonAbout KRNT Kornit Digital Ltd.
Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.